Which medication is preferred for treating orthostatic hypotension in an elderly patient with heart failure?
A 72-year-old female with a history of atrial fibrillation on warfarin presents with acute flank pain. A CT scan reveals a large perinephric hematoma. What is the most appropriate management option for this patient?
A patient on long-term NSAID therapy develops peptic ulcer disease. What approach should be taken to manage both conditions effectively?
In which of the following conditions is hyperbaric oxygen therapy not useful?
Which of the following is an absolute CONTRAINDICATION to OCP use:
Which fluid is ideally given for a patient experiencing dehydration?
Use of spironolactone in liver cirrhosis is
Site for injection of cell culture rabies vaccine-
Which drug should not be given in a patient with hyperrenninemia?
A 42-year-old man was seen in the clinic because of pain and redness in his finger. Last week he had injured the finger while working in his garage. On physical examination, there is erythema, swelling, and tenderness of the second digit in the right hand. Flexion and extension of the finger were normal. A clinical diagnosis of cellulitis is made and he is prescribed cephalexin. A few days later he presents to the emergency room complaining of difficulty breathing. He has angioedema due to a drug reaction to the cephalexin. Which of the following physical findings is characteristic of this syndrome?
Explanation: ***Midodrine; a direct vasoconstrictor*** - **Midodrine** is an alpha-1 adrenergic agonist that causes **vasoconstriction**, directly increasing peripheral vascular resistance and blood pressure to treat orthostatic hypotension. - It is preferred in patients with **heart failure** because, unlike fludrocortisone, it has minimal effects on plasma volume and does not exacerbate fluid overload, a common concern in heart failure [1]. *Fludrocortisone; increases blood volume* - **Fludrocortisone** is a mineralocorticoid that promotes **sodium and water retention**, thereby increasing intravascular volume. - While effective for orthostatic hypotension, it can worsen **fluid overload** and **heart failure symptoms** due to its volume-expanding properties, making it a less suitable first-line choice in this population [1]. *Neither; lifestyle modifications are preferred* - While **lifestyle modifications** (e.g., increased fluid and salt intake, compression stockings, slow position changes) are crucial for managing orthostatic hypotension, they are often insufficient alone in elderly patients with symptomatic conditions like heart failure. - Pharmacological intervention is frequently required to achieve adequate symptom control and prevent falls [1]. *Both are equally appropriate; combine for better effect* - **Midodrine** and **fludrocortisone** are not equally appropriate for an elderly patient with heart failure, as fludrocortisone poses a higher risk of worsening heart failure due to volume expansion. - Combining medications without careful consideration of potential adverse effects, especially in a vulnerable patient population like those with heart failure, is generally discouraged unless specific indications outweigh the risks.
Explanation: **Reversal of anticoagulation to prevent further bleeding in the context of a perinephric hematoma.** - The presence of a **large perinephric hematoma** in a patient on **warfarin** indicates active bleeding or a significant risk of further bleeding, necessitating immediate reversal of anticoagulation. [1] - Reversal can be achieved using **Vitamin K** and/or **four-factor prothrombin complex concentrate (4F-PCC)**, depending on the urgency and severity of bleeding and the patient's INR. *Continue anticoagulation despite the hematoma.* - Continuing anticoagulation would **exacerbate the bleeding** into the perinephric space, potentially leading to hemodynamic instability, increased pain, and larger hematoma size. - This approach would be **medically irresponsible** given the documented bleeding event, as it would directly oppose efforts to control hemorrhage. *Observation with close monitoring without intervention.* - While monitoring is crucial, **mere observation without intervention** is insufficient when there's an active or high-risk bleed due to anticoagulation, especially with a "large" hematoma. - This approach risks **cardiovascular compromise** from blood loss (e.g., hypovolemic shock) and further kidney damage due to compression from the expanding hematoma. *Surgical evacuation of the hematoma as a first-line treatment.* - **Surgical evacuation** of a perinephric hematoma is typically reserved for cases where bleeding continues despite anticoagulation reversal, there is evidence of **renal ischemia**, or the patient becomes **hemodynamically unstable** despite conservative measures. - It is an **invasive procedure** with associated risks and is not the initial management step when bleeding is likely due to therapeutic anticoagulation.
Explanation: ***Switch to a COX-2 inhibitor and start a proton pump inhibitor*** - A **COX-2 inhibitor** provides anti-inflammatory effects with less gastrointestinal toxicity compared to traditional NSAIDs, as it selectively inhibits the COX-2 enzyme which is responsible for inflammation while sparing COX-1, which protects the gastric mucosa [1], [3]. - A **proton pump inhibitor (PPI)** effectively suppresses gastric acid secretion, promoting the healing of existing ulcers and preventing new ones, offering superior protection compared to H2 receptor antagonists for NSAID-induced ulcers. *Continue NSAID and add an H2 receptor antagonist* - Continuing the same **NSAID** would likely exacerbate the peptic ulcer disease due to its non-selective inhibition of COX-1, which is crucial for gastric protection [3]. - **H2 receptor antagonists** are generally less effective than proton pump inhibitors in healing and preventing NSAID-induced ulcers, especially in patients with existing disease [2]. *Discontinue NSAID and switch to acetaminophen* - While discontinuing the NSAID would remove the primary cause of the ulcer, **acetaminophen** may not provide sufficient anti-inflammatory or analgesic effects for the patient's underlying condition requiring long-term NSAID therapy. - This approach might be suitable if the patient's condition for which NSAIDs are prescribed could be managed effectively with a non-NSAID alternative, but it doesn't address the ongoing need for anti-inflammatory treatment. *Add a high-dose antacid regimen* - **Antacids** provide only symptomatic relief by neutralizing stomach acid and do not effectively heal existing ulcers or prevent new ones in the context of ongoing NSAID use [2]. - A high-dose antacid regimen is impractical for long-term management and does not suppress acid production as effectively as PPIs or H2 blockers.
Explanation: ***Compartment Syndrome*** - **Hyperbaric oxygen therapy (HBOT)** is not a primary or generally recommended treatment for compartment syndrome. - The main treatment for **compartment syndrome** is urgent surgical fasciotomy to relieve pressure, as HBOT does not address the underlying mechanical compression of vessels and nerves. *Anemia* - While HBOT directly increases dissolved oxygen in plasma, it **does not increase the red blood cell count** or **hemoglobin levels**, which are the fundamental deficiencies in anemia [1]. - Therefore, it is not a primary treatment for anemia, though it can be a supportive measure in severe cases where conventional methods are delayed or insufficient [1]. *Gas gangrene* - **Clostridium perfringens**, the causative agent of gas gangrene, is an **anaerobic bacterium** that thrives in low-oxygen environments. - **Hyperbaric oxygen** creates an oxygen-rich environment that is toxic to these bacteria and enhances the body's immune response, making it an effective adjunctive treatment. *Vertigo* - **Vestibular vertigo** can sometimes be associated with inner ear ischemia or damage from pressure changes, for which HBOT may offer benefit by improving oxygen delivery to the affected tissues [2]. - Its use for vertigo is more investigational, but **improvement in oxygenation and reduction in inflammation** could theoretically alleviate symptoms in certain labyrinthine disorders [2].
Explanation: ***DVT*** - A **history of DVT** (deep vein thrombosis) is an absolute contraindication for **combined oral contraceptive pills (OCPs)** due to the increased risk of **thrombosis**. - OCPs, particularly those containing estrogen, elevate the risk of **venous thromboembolism (VTE)** by affecting coagulation factors. *Diabetes mellitus* - **Uncontrolled diabetes** with vascular complications (nephropathy, retinopathy, neuropathy) is generally a contraindication, but **well-controlled diabetes** without these issues is not. - OCPs can slightly affect **glucose metabolism**, but the benefits often outweigh the risks in controlled cases. *History of amenorrhea* - A history of **amenorrhea** (absence of menstruation) is not an absolute contraindication to OCP use. - OCPs can often be used to **regulate menstrual cycles** or in diagnostic workups for amenorrhea. *Chronic renal disease* - **Chronic renal disease** in itself is not an absolute contraindication; the decision depends on the **severity of the disease** and associated complications. - OCP use might require careful monitoring in patients with severe renal impairment, but it is not universally prohibited.
Explanation: ***Normal Saline*** - **Normal saline (0.9% sodium chloride)** is an **isotonic solution** that effectively increases **extracellular fluid volume**, making it ideal for treating **dehydration** and hypovolemia [1]. - It closely mimics the **osmolality of plasma** and stays predominantly in the intravascular space, helping to restore circulating volume [1]. *Plasma* - **Plasma** is primarily used for **coagulation factor deficiencies** or volume expansion in cases of severe **hypoproteinemia**, not routine dehydration. - It contains **proteins and clotting factors** that are not typically needed for simple dehydration and carries risks of **allergic reactions and transfusion-related acute lung injury (TRALI)**. *Blood* - **Blood transfusions** are indicated for patients with **significant anemia** or **acute blood loss**, not for generalized dehydration. - Using blood for dehydration would be inappropriate due to risks such as **transfusion reactions**, **infections**, and **iron overload**. *5% dextrose* - **5% dextrose in water (D5W)** is an **isotonic solution initially**, but once the dextrose is metabolized, it becomes **hypotonic**, causing free water to shift into the cells [1]. - While it provides some free water, it is not ideal for primary rehydration in cases of significant volume depletion due to its lack of electrolytes and potential for causing **hyponatremia** if given in large quantities [1].
Explanation: ***Decrease edema*** - Spironolactone is an **aldosterone antagonist** that blocks the effects of aldosterone, which is often elevated in liver cirrhosis. - By antagonizing aldosterone, spironolactone promotes **sodium and water excretion**, directly leading to a reduction in **ascites and peripheral edema** [1]. *May improve liver function indirectly* - While spironolactone manages complications of liver cirrhosis, it does **not directly improve liver function** or reverse liver damage. - Its primary role is in **symptom management**, particularly fluid retention, not in healing the underlying liver disease. *May decrease afterload* - Spironolactone's primary action is on the **kidneys** to promote diuresis; it is **not a vasodilator** and therefore does not directly decrease cardiac afterload. - Any effect on systemic vascular resistance would be minimal and secondary to volume changes rather than a direct vasodilatory property. *May decrease intravascular volume* - Spironolactone **decreases total body sodium and water**, leading to a reduction in extravascular fluid (edema and ascites) [1]. - While it decreases the total amount of fluid in the body, its main effect is on **extravascular volume**, and it's chosen over loop diuretics in cirrhosis to prevent **excessive intravascular depletion** which can worsen renal function.
Explanation: Deltoid - The **deltoid muscle** is the recommended site for intramuscular injection of cell culture rabies vaccine due to its size and accessibility [1]. - Intramuscular administration in this area ensures optimal vaccine absorption and immunogenicity [1]. Gluteus - The **gluteus muscle** is not the preferred site for rabies vaccine due to the risk of injecting into fat, which can lead to reduced immune response [1]. - Additionally, there is a higher risk of **sciatic nerve injury** with gluteal injections. Subcutaneous - **Subcutaneous administration** is not the standard route for cell culture rabies vaccines as it can lead to slower absorption and potentially a less robust immune response. - This route is typically reserved for specific vaccine types or in situations where intramuscular injection is contraindicated. Anterior abdominal wall - The **anterior abdominal wall** is an unsuitable site for intramuscular injection of rabies vaccine. - This area is primarily used for **subcutaneous injections** (e.g., insulin) and lacks sufficient muscle mass for effective intramuscular vaccine delivery.
Explanation: None of the options - This is the correct answer because drugs used to treat hypertension often aim to **reduce renin activity** or its effects, making them appropriate for hyperreninemia. - Hyperreninemia indicates an overactive **renin-angiotensin-aldosterone system (RAAS)**, and all the listed drug classes can be used to manage conditions associated with it [2]. *Beta blocker* - **Beta-blockers** reduce renin secretion from the **juxtaglomerular cells** by blocking beta-1 adrenergic receptors [2]. - Therefore, they are often used to *treat* conditions involving high renin levels, making them suitable rather than contraindicated. *Calcium channel blocker* - **Calcium channel blockers** reduce peripheral vascular resistance and can lower blood pressure, but they do not directly inhibit renin secretion [1]. - However, they are not contraindicated in hyperreninemia and may be used as part of a multidrug regimen to control blood pressure. *ACE inhibitor* - **ACE inhibitors** block the conversion of **angiotensin I to angiotensin II**, thus directly interrupting the RAAS pathway [1]. - This action helps to *lower* blood pressure and can be beneficial in hyperreninemia, making it a treatment rather than a contraindicated drug [1].
Explanation: ***Involvement of lips, tongue, eyelids, genitalia, and dorsum of hands or feet*** - **Angioedema** is characterized by episodic, localized swelling of the deeper dermal and subcutaneous tissues, often affecting the **lips, tongue, eyelids, genitalia, and dorsum of hands or feet** [1]. - This distribution is due to the **loose connective tissue** in these areas, which allows for significant fluid accumulation. *Invariably severe itching* - While angioedema can sometimes be accompanied by itching, **severe itching (pruritus)** is more characteristic of **urticaria** (hives), which involves the superficial dermis [1]. - In many cases of angioedema, particularly **bradykinin-mediated types**, itching is absent or minimal. *Prolonged nature of the edema* - The edema in **angioedema** typically resolves within **24 to 72 hours**, not weeks or months, differentiating it from other chronic inflammatory conditions. - Its self-limiting nature is a key diagnostic feature, although recurrence is common. *Fluid extravasation from subcutaneous and intradermal postcapillary venules* - **Fluid extravasation** from postcapillary venules occurs in both urticaria and angioedema. However, in angioedema, the fluid extravasation occurs at the level of the **deep dermis and subcutaneous tissue**, leading to deeper swelling. - In **urticaria**, the extravasation is more superficial, affecting the **epidermis and superficial dermis**, resulting in itchy wheals.
Pharmacokinetics and Pharmacodynamics
Practice Questions
Drug Metabolism and Excretion
Practice Questions
Adverse Drug Reactions and Interactions
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Pharmacogenomics and Precision Medicine
Practice Questions
Drug Development and Clinical Trials
Practice Questions
Rational Prescribing and Deprescribing
Practice Questions
Medication Adherence Strategies
Practice Questions
Special Populations (Pediatric, Geriatric, Pregnancy)
Practice Questions
Pharmacovigilance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free